
Opinion|Videos|April 3, 2025
Discussing ADC Risks, Benefits, and Regimens With Patients
Panelists discuss how health care professionals use clear, tailored communication to explain antibody-drug conjugate (ADC) risks, benefits, and regimens. They provide education, address concerns, and ensure adherence through counseling and shared decision-making.
Advertisement
Episodes in this series

Video content above has been prompted by the following:
- At your institution, how do you effectively communicate with patients about ADC therapies (eg, risks, benefits, treatment regimens)?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Can Close the LDL Control Gap in Lipid Care
2
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
3
FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy
4
Building a CDTM Program Means Starting Small
5



































































































